Industry Insight
Information, Observation & Analysis
Vaccines Articles
Cancer vaccines are proving to be a pillar of personalized treatment.
While there are many vaccines, not every promising vaccine has progressed to market, such as the vaccine for West Nile virus.
Respiratory syncytial virus (RSV) can be especially serious for infants and older adults, but vaccines can help reduce the burden on at-risk populations.
While traditional vaccines teach the immune system to fight off foreign invaders, inverse vaccines teach the immune system to ignore its own cells — and may completely reverse autoimmune disease.
Shortages and recent spikes in egg prices have boosted public awareness that a “bird flu” is devastating domestic poultry flocks across the country. Since its arrival in the U.S. in January 2022, more than 166 million farmed poultry animals have been sacrificed in an attempt to control the spread of H5N1, a highly pathogenic avian influenza A (HPAI) featuring H5 hemagglutinin and N1 neuraminidase surface proteins (H5N1).
The incidence and prevalence of STIs remain high, and the serious health consequences of contracting one make prevention a national imperative.
Protecting Americans against severe disease significantly reduces their chances of getting seriously sick while traveling abroad.
Though mostly eradicated in the U.S., treatment for rabies must begin immediately with hyperimmune globulin and vaccines.
Three top vaccine producers are making newer vaccines that not only protect against the newer sublineages of COVID-19, but that also protect against other respiratory viruses.
Although history has proven the success of vaccines in controlling the spread of diseases, emerging threats are concerning. However, hope is on the horizon with studies of newer vaccines.